TABLE 3.
Details of the discrepant results by LIA and WB among the finally confirmed HTLV positive samples.
Sample no. | ELISA |
CLIA |
LIA |
WB 2.4 |
qPCR |
|||||
Avioq | Murex | Roche | Fujirebio | Bands pattern | Results | Bands pattern | Results | PVL | Results | |
S/CO | S/CO | S/CO | COI | |||||||
1626 | 1.787 | 3.315 | 427.9 | 50.0 | p19 I/II, p24 I/II, gp46 I/II, gp21 I/II, gp46-I | HTLV-1 | p19, p24, p26, p28, p32, p36, p53, pg46 | Ind | 0.339 | HTLV-1 |
1705 | 1.166 | 3.297 | 77.8 | 50.0 | p19 I/II, gp46 I/II, gp21 I/II, gp46-I | HTLV-1 | p19, rgp46-I | Ind | 11.397 | HTLV-1 |
359 | 5.323 | 9.409 | 343.9 | 50.0 | p19 I/II, p24 I/II, gp46 I/II, gp21 I/II | HTLV | p19, p24, p26, p28, p32, p36, p53, GD21, rgp46-I | HTLV-1 | / | NT |
1739 | 1.146 | 3.49 | 178.2 | 50.0 | p19 I/II,gp21 I/II, gp46-I | HTLV | p19, p26, p28, GD21 | Ind | 0.009 | HTLV-1 |
525 | 0.14 | 0.43 | 1.12 | 3.1 | gp46 I/II, gp21 I/II, gp46-I | HTLV-1 | / | Neg | / | NT |
495 | 0.19 | 0.40 | 1.9 | 8.4 | p19 I/II, gp21 I/II | HTLV | / | Neg | / | NT |
1441 | 0.34 | 0.55 | 11.95 | 5.6 | p19 I/II, gp21 I/II | HTLV | p19 | Ind | / | Neg |
1747 | 0.074 | 2.02 | 42.31 | 0.6 | p19 I/II, gp21 I/II | HTLV | rgp46-II | Ind | / | Neg |
53 | 0.142 | 2.212 | 0.215 | 1.8 | p24 I/II, gp21 I/II | HTLV | / | Neg | / | NT |
1412 | 0.17 | 2.59 | 0.472 | 1.3 | p19 I/II, gp21 I/II | HTLV | / | Neg | / | NT |
816 | 0.24 | 1.86 | 0.136 | 0.3 | p19 I/II, gp21 I/II | HTLV | p19, p26 | Ind | / | NT |
1295 | 0.15 | 1.02 | 0.4 | 0.9 | p19 I/II, p24 I/II, gp21 I/II | HTLV | / | Neg | / | Neg |
489 | 0.16 | 0.35 | 5.18 | 0.1 | p19 I/II, gp21 I/II | HTLV | / | Neg | / | NT |
647 | 0.13 | 0.45 | 4.15 | 0.9 | p19 I/II, gp21 I/II | HTLV | / | Neg | / | NT |
1285 | 0.29 | 0.36 | 1.32 | 0.7 | p24 I/II, gp21 I/II | HTLV | / | Neg | / | NT |
1461 | 0.32 | 0.38 | 1.47 | 0.4 | p24 I/II, gp21 I/II | HTLV | / | Neg | / | Neg |
457 | 0.190 | 0.780 | 0.727 | 3.1 | p19 I/II, gp21 I/II | HTLV | / | Neg | / | NT |